Chemomab Therapeutics Ltd. (CMMB) › Total LiabilitiesChemomab Therapeutics Ltd. (CMMB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2018: $2.96M2019: $4.85M2020: $1.67M2021: $2.89M2022: $6.84M2023: $5.15M2024: $3.43M2025: $1.48M$1.48M2018Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$1.48M-56.9%2024$3.43M-33.5%2023$5.15M-24.6%2022$6.84M+136.9%2021$2.89M+72.5%2020$1.67M-65.5%2019$4.85M+63.9%2018$2.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share